2023 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar

2023癌症纳米技术戈登研究大会暨戈登研究研讨会

基本信息

  • 批准号:
    10609291
  • 负责人:
  • 金额:
    $ 0.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Abstract The 2023 Cancer Nanotechnology Gordon Research Conference (CN-GRC) provides a unique and highly acclaimed forum where scientists at every stage of their career can share unpublished, innovative cancer research made possible by the use of nanotechnology. Held biennially since 2011, the conference has had a strong and steadily growing attendance. To further support the emerging generation of scientists in this field, the Cancer Nanotechnology Gordon Research Seminar (CN-GRS) will be carried out in conjunction with the GRC, highlighting talks by graduate students and postdocs. This conference is an important venue bringing together chemists, physicists, engineers, biologists, clinicians, industry leaders and regulatory experts focused on the highly interdisciplinary science of cancer nanotechnology. This meeting will particularly focus on two ends of the spectrum in cancer research: deepening our fundamental understanding of the interactions of nanomaterials with tumors and the in vivo environment, and translation of cancer nanotechnology out of the lab and into the clinic. The conference will bring together a lively group of exceptional scientists to peaceful and scenic Waterville Valley, NH in order to: 1) share cutting-edge research in cancer nanotechnology by experts representing the whole spectrum of life sciences; 2) foster discussion, exchange of ideas, and promote collaborations and 3) enhance the training and development of young scientists and promote diversity. A high priority of the CN-GRC and CN- GRS is to increase the diversity of participants. Towards this goal, funds are requested for travel and registration support of female and under-represented speaker
摘要 2023年癌症纳米技术戈登研究会议(CN-GRC)提供了一个独特和高度 广受好评的论坛,在这里,处于职业生涯各个阶段的科学家可以分享未发表的、创新的癌症 纳米技术的使用使研究成为可能。自2011年以来,该会议每两年举行一次, 上座率强劲且稳步增长。为了进一步支持这一领域的新兴一代科学家, 癌症纳米技术戈登研究研讨会(CN-GRS)将与 GRC,重点介绍研究生和博士后的演讲。这次会议是一个重要的会场,带来了 化学家、物理学家、工程师、生物学家、临床医生、行业领袖和监管专家共同关注 关于癌症纳米技术这一高度交叉的科学。本次会议将特别关注两个问题 癌症研究的两端:加深我们对癌症相互作用的基本理解 纳米材料与肿瘤和体内环境,以及癌症纳米技术的实验室转化 然后进了诊所。 会议将把一群活跃的杰出科学家聚集在宁静而风景秀丽的沃特维尔 为了:1)由代表国家和地区的专家分享癌症纳米技术的尖端研究 生命科学的全部领域;2)促进讨论、思想交流和促进合作;3) 加强青年科学家的培养和发展,促进多样性。CN-GRC的高度优先事项 CN-GRS是为了增加参与者的多样性。为实现这一目标,请拨经费用于旅行和 向女性和代表不足的发言者提供登记支助

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Darrell J Irvine其他文献

Interleukin-7 Receptor Signaling Network: An Integrated Systems Perspective
白细胞介素-7 受体信号网络:综合系统视角
  • DOI:
    10.1038/cmi.2008.10
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
    19.800
  • 作者:
    Megan J Palmer;Vinay S Mahajan;Lily C Trajman;Darrell J Irvine;Douglas A Lauffenburger;Jianzhu Chen
  • 通讯作者:
    Jianzhu Chen
Big thinking for adjuvants
佐剂的大思维
  • DOI:
    10.1038/nbt.3398
  • 发表时间:
    2015-11-06
  • 期刊:
  • 影响因子:
    41.700
  • 作者:
    Eric L Dane;Darrell J Irvine
  • 通讯作者:
    Darrell J Irvine
Systemic delivery of liposome-anchored anti-CD137 and IL2-Fc prevents lethal toxicity and elicits potent antitumor immunity
  • DOI:
    10.1186/2051-1426-3-s2-p318
  • 发表时间:
    2015-11-04
  • 期刊:
  • 影响因子:
    10.600
  • 作者:
    Yuan Zhang;Darrell J Irvine
  • 通讯作者:
    Darrell J Irvine
T lymphocyte engineering with cytokine nanogels for enhanced cancer immunotherapy
  • DOI:
    10.1186/2051-1426-3-s2-p54
  • 发表时间:
    2015-11-04
  • 期刊:
  • 影响因子:
    10.600
  • 作者:
    Li Tang;Yiran Zheng;Llian Mabardi;Darrell J Irvine
  • 通讯作者:
    Darrell J Irvine

Darrell J Irvine的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Darrell J Irvine', 18)}}的其他基金

"Extended dosing" immunization to enhance humoral immunity to next-generation vaccines
“延长剂量”免疫增强对下一代疫苗的体液免疫
  • 批准号:
    10638732
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
Localized immunotherapy using alum-binding therapeutics
使用明矾结合疗法的局部免疫疗法
  • 批准号:
    10495228
  • 财政年份:
    2021
  • 资助金额:
    $ 0.5万
  • 项目类别:
Localized immunotherapy using alum-binding therapeutics
使用明矾结合疗法的局部免疫疗法
  • 批准号:
    10686236
  • 财政年份:
    2021
  • 资助金额:
    $ 0.5万
  • 项目类别:
Localized immunotherapy using alum-binding therapeutics
使用明矾结合疗法的局部免疫疗法
  • 批准号:
    10367044
  • 财政年份:
    2021
  • 资助金额:
    $ 0.5万
  • 项目类别:
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
通过嵌合受体加强疫苗增强 CAR-T 细胞对抗实体瘤的活性
  • 批准号:
    10540783
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
通过嵌合受体加强疫苗增强 CAR-T 细胞对抗实体瘤的活性
  • 批准号:
    10322393
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
SpongeBot: genetically engineered cells to suppress SARS-CoV-2 and future viruses
SpongeBot:基因工程细胞抑制 SARS-CoV-2 和未来病毒
  • 批准号:
    10186867
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
有针对性地递送细胞病变增强剂,并与休克和杀伤相配合,以减少艾滋病毒储存库
  • 批准号:
    10207378
  • 财政年份:
    2019
  • 资助金额:
    $ 0.5万
  • 项目类别:
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
有针对性地递送细胞病变增强剂,并与休克和杀伤相配合,以减少艾滋病毒储存库
  • 批准号:
    10447148
  • 财政年份:
    2019
  • 资助金额:
    $ 0.5万
  • 项目类别:
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
有针对性地递送细胞病变增强剂,并与休克和杀伤相配合,以减少艾滋病毒储存库
  • 批准号:
    10656269
  • 财政年份:
    2019
  • 资助金额:
    $ 0.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了